Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
The Ayushman Bharat Digital Mission can be seen as a digital highway connecting various players across the healthcare ecosystem.
It will transform the country's health landscape and ensure ease of living for patients & health-care service providers.
Dr. Mansukh Mandaviya
Minister of Health and Family Welfare
Govt. Of India
Sponsor
Patient Safety Capsules
World Consumer Rights Day 2022: #Fairdigitalfinance
"Through advancement in technology and a focus on the consumer, fintechs are leading the way in financial inclusion" Luvleen Sidhu
Pharma export registers decline of 3.13% in February
New Delhi, March 12, 2022: Exports of pharmaceuticals from the country registered a decline of 3.13 per cent during February, 2022, to $1.94 billion as compared to $2 billion in the same month of last year. The 11 month period from April 2021 has reported a marginal growth of 0.16 per cent, as compared to the same period of previous fiscal year.
Drug Laws & Policy Injections
NITI Aayog to expand 'Medicines from the Sky' project, explores emerging technologies in medical sectorNew Delhi, March 12, 2022: NITI Aayog, the policy think tank of the Government of India, is looking at expanding its “Medicines from the Sky” project, which uses unmanned aerial systems for the delivery of vaccines in remote areas, to the North-Eastern parts of the country. It is also exploring use of emerging technologies including artificial intelligence (AI) in medical diagnostics.
SC issues notice to Centre on petition to establish statutory powers for ethical marketing in pharma New Delhi, March 15, 2022: A Division Bench of the Supreme Court has issued a notice to the Government of India in a petition filed by the Federation of Medical and Sales Representatives Association (FMRAI) and others seeking establishment of a Statutory Code of ethical marketing for the pharmaceutical industry with provisions for penal actions against violators.
DoP extends timeline to apply for leftover slots under PLI schemeNew Delhi, March 15, 2022: The Department of Pharmaceuticals (DoP) has extended timeline for the industries to submit application under the production linked incentive PLI SCHEME for promotion of domestic manufacturing of critical key starting materials (KSMs),
SC agrees to review application for code to prevent unfair marketing practices by Pharma companiesNew Delhi, March 12, 2022: The Supreme Court on Friday approved a motion seeking direction to the Center for the establishment of a Uniform Code of Pharmaceutical Marketing Practices to prevent misconduct by Pharma companies and ensure to a proper inspection, knowledge, responsibility and consequences of wrongdoing.
DoP selects three agencies to conduct study on five topics in pharma and medical devices sectorsNew Delhi, March 17, 2022: The Department of Pharmaceuticals (DoP) has selected three agencies to work with the Government of India and submit reports on five studies on pharma and medical devices sectors in the country to help it frame policies, monitoring and corrective measures.
TPS demands streamlining of pharmacy council in Telangana to strictly impose Pharmacy ActHyderabad, March 16, 2022: The Telangana Pharmacy Society (TPS) has demanded that it is high time to streamline the Telangana State Phar-macy Council (TSPC) to strictly impose the Pharmacy Act and protect the interests of pharmacists in the state.
Pharma Injections
SII seeks Covovax’s inclusion in Covid vaccination drive for 12 years and aboveNew Delhi, March 15, 2022: Serum Institute of India has urged the Union government to include Covovax in the National COVID-19 Vaccination programme for inoculating those aged 12 years and above, official sources said on Tuesday.
Pharma imports grow 14 per cent in FebruaryNew Delhi, March 17, 2022: Import of pharmaceutical products for the month of February has seen an increase of 14.18 per cent, in continuation with the growth it has been marking in the past. The growth has been significant for the first 11 months of the fiscal year, crossing Rs. 60,000 crore mark in rupee terms.
SPEs demand framing of statutory working rules in pharma industry New Delhi, March 16, 2022: The sales promotion employees (SPEs) in the pharmaceutical industry have decided to intensify its country-wide movement to put pressure on the government to frame statutory working rules alleging “unbearable exploitation and victimisation” in the absence of such rules.
ViiV Healthcare’s readiness for voluntary licensing for cabotegravir augurs well for Indian HIV patients Mumbai, March 14, 2022: Succumbing to pressure from Médecins Sans Frontières (MSF), the US-based pharmaceutical company ViiV Healthcare has withdrawn its decision of rolling back voluntary licensing deal for long-acting injectable cabotegravir (CAB-LA) which is used to prevent HIV infection. This will pave the way for development of low-cost generic formulations in low-and middle-income countries (LMICs) including India.
O4S raises $6 mn to grab pharma orders after Union govt mandates QR code on API packs from Jan-2023 Bengaluru, March 12, 2022: Indian pharma is now resolute to invest in platform technologies to accelerate connectivity, reliability, and visibility into the supply chain. This follows after the Union government notification for pharma manufacturers to include QR code in every API pack manufactured or imported in India by January 2023.
TGA approves one-dose Kozenis for children with P. vivax malaria March 14, 2022: Medicines for Malaria Venture (MMV) The Australian Therapeutic Goods Administration (TGA) has an-nounced the use of a single-dose Kozenis (tafenoquine) in children aged two years and older in combina-tion with chloroquine for radical treatment (prevention of recurrence.) of Plasmodium vivax (P. vivax) malaria.
Drug Dopes
Leaving for home during Cov, nurses begin to return to the city Pvt HospitalsKOLKATA, March 13, 2022: Nurses who left private hospitals in Kolkata soon after the onset of the disease two years ago are starting to return to hospitals. More than 800 nurses have left their jobs and returned to their respective states – mostly in the Northeast, Odisha, Kerala and Jharkhand – severely hampering medical services. That was left over the last two years. With the reduction of Covid fears, about 40% have returned to most hospitals to return to normal practice. 
Safdarjung Hospital hosts state -of -the -art dialysis clinicsNew Delhi, March 12, 2022: The nephrology department of Safdarjung Hospital has started using hemodiafiltration (HDF) machines for better cleansing of patients during dialysis. To this end, a new ward with two machines was set up to treat dialysis patients.
Researchers develop unique biomimetic cornel hydrogel from discarded human corneas Hyderabad, March 15, 2022: Researchers from leading institutions like Centre for Cellular and Molecular Biology (CCMB), LV Prasad Eye Institute (LVPEI) and IIT Hyderabad have developed a unique biomimetic corneal hydrogel, made up of discarded human corneas, which can be used to treat corneal scarring, a major cause of corneal blindness.
KPRDO asks KSPC to increase its funds from Rs. 2 lakh to Rs. 5 lakh for families of deceased pharmacists Bengaluru, March 17, 2022: The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has proposed to the Karnataka State Phar-macy Council (KSPC)’s Registered Pharmacists Welfare Trust to increase its funding from the current Rs. 2 lakh to Rs. 5 lakh for the families of deceased pharmacists. The initiative is part of the Trust’s community programme extending a small financial support to the deceased pharmacists family.
Global pharma’s interest in targeted therapy set to increase as US FDA issues new norms on patient-focused drug development Bengaluru, March 15, 2022: Global pharma will now be able to further increase its pace of research in targeted drug therapy with the recent US FDA guidance on Patient-Focused Drug Development: Methods to Identify What Is Important to Patients.
DoP calls for applications for pharma and medical devices awards 2022New Delhi, March 16, 2022: The Department of Pharmaceuticals (DoP) has called for application from eligible companies from the pharmaceuticals and medical devices industry in the country for the seventh India-pharma and medical devices award programme to motivate the inventors to carry out innovative research and development in the areas of pharmaceuticals, bio-pharma, medical devices and allied industry.
National Injections
TN drug officials seize spurious drugs worth Rs one lakh from two wholesale premises in Virudunagar district Chennai, March 16, 2022: In a major raid conducted in two wholesale premises in Virudunagar district in Tamil Nadu, the sleuths of the ADC office there seized spurious drugs worth Rs one lakh, and cases were charged against the wholesalers for contravention of provisions of sale licences.
Odisha govt’s cadre rule for drug controller annoys senior regulatory officersBhuwaneshwar, March 14, 2022: The cadre rule created by the government of Odisha for the post of Drug Controller becomes a bottleneck for the senior regulatory officers who are now feeling hassled and annoyed as they find it is onerous to reach upto the topmost post, it is learnt.
Pondicherry govt seeks support of Covid warriors to implement programmes to manage post-Covid-19 complications Chennai, March 17, 2022: The Government of Pondicherry has sought the cooperation and support of all health workers including pharmacists, who worked as Covid-19 warriors in the last two years, to assist the UT Government in its programs to manage the post-Covid complications that are found in certain people with various illnesses.22.
Pharmacists in Odisha to complain to state govt against OSPC registrar for not initiating election process Bhuwaneshwar, March 15, 2022: At a time when all state pharmacy councils in India are preparing to celebrate the 75th anniversary of the Pharmacy Act 1948, the pharmacists and professionals of pharmacy in Odisha are in a dilemma as there is not an elected council in the state to direct and guide the professionals for the one-year celebration programme mooted by the PCI.
Researchers call for clarity about the ‘health problem’ March 10, 2022: A new review of models used around the world to assess, diagnose, research, and manage mental health problems reveals a number of avenues that exist.
India released from RT-PCR test before leaving New Delhi, March 12, 2022: PeoFull training in India does not currently require a poor RT PCR test report on return from the UAE to the country. They can upload their travel certificate of India.
Global Injections
WHO seeks when and how to report Covid crisisGeneva, March 14, 2022: Health professionals at the World Health Organization have begun discussing how and when to end the global Covid-19 crisis, finding a more important solution more than two years later. the onset of the disease.
Doctors and volunteers try to support Ukraine’s health systemLondon, March 15, 2022: When Russian shelling began to fall on Kyiv, Nataliia Verovkina, an oncologist, and her 10 -year -old son fled. But when he was safe in Munich with his grandparents, he turned and returned.
Viatris' copycat to AstraZeneca blockbuster Symbicort passes FDA muster, but legal battle delays launch
March 16, 2022: Viatris appears to be on a roll with "complex generic" approvals. Just a month after its Restasis copycat nod, the company has scored the first FDA approval for a generic to AstraZeneca's big-selling Symbicort, teeing up a potential launch later this year.
Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month data
March 16, 2022: After posting mixed late-stage data last fall and securing FDA support to include midstage data in its approval application for pegcetacoplan in geographic atrophy (GA), Apellis has been awaiting one last set of results before proceeding to the agency. Now, with those 18-month data in hand, the company is getting its regulatory package together for a filing next quarter.
Covid deaths probably three times higher than records say
March 11, 2022: Their report comes two years to the day from when the World Health Organization first declared the pandemic. The Covid-19 excess mortality team at the US's Washington University studied 191 countries and territo-ries for what they call the true global death figure.
The tragedy of Afghanistan's malnourished children
March 16, 2022: Amidst the heart-rending sound of dozens of hungry babies crying, and desperate pleas for help from their mothers, nurses scramble to prioritise children who need urgent care. There are many such babies.
PSAIIF PILL
DoP releases approach paper to National Medical Device Policy to make India “Diagnostic Capital of the World”
New Delhi, March 14, 2022: The Department of Pharmaceuticals (DoP) has released an approach paper to the National Medical Device Policy, a draft for stakeholder discussion, to position the country as the true “Diagnostic Capital of the World”. The Policy, which envisages various developments including setting up of NIPER-like institutions for the medical devices sector, is expected to be valid for a period of 10 years following which it will be revised.
DoP combines existing schemes to announces new scheme ‘Strengthening of Pharmaceutical Industry’
New Delhi, March 14, 2022: The Department of Pharmaceuticals (DoP) has combined the existing schemes for the development of pharmaceutical industries into a single scheme of Strengthening of Pharmaceutical Industry (SPI) with modification in the scheme guidelines, to strengthen the existing infrastructure facilities with a total financial outlay of Rs. 500 crore.
Frequently Asked Questions
Do liquid diets work and are they safe?
So how safe are these diets and what is their effect on the body? There are many different kinds of liquid diets but they all have the same aim - to lose weight quickly by eating fewer calories.
SUBSCRIBER'S SYMPTOM
Air pollution exposure linked to increased autoimmune disease risk: Study
March 16, 2022: Long-term exposure to air pollution is associated with an increased risk of autoimmune disease, particu-larly rheumatoid arthritis, connective tissue and inflammatory bowel diseases, according to an on obser-vational study.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Ms. Aarohi, Haridwar It's awesome, really, I can't say enough about how well it's tailored to cover healthcare news from all around..
Ms. Shahina Saba, KolkataThank you for all of your hard work and dedication in publishing such an updated newsletter.
Mr. Jagdish Tyagi, Gaya
I love the approachable format and the articles that PSAI choses to feature in their Newsletter. Good work, Keep it up!
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
